DK0708093T3 - Quinoxaliner, fremgangsmåde til fremstilling deraf og deres anvendelse - Google Patents

Quinoxaliner, fremgangsmåde til fremstilling deraf og deres anvendelse

Info

Publication number
DK0708093T3
DK0708093T3 DK95116094T DK95116094T DK0708093T3 DK 0708093 T3 DK0708093 T3 DK 0708093T3 DK 95116094 T DK95116094 T DK 95116094T DK 95116094 T DK95116094 T DK 95116094T DK 0708093 T3 DK0708093 T3 DK 0708093T3
Authority
DK
Denmark
Prior art keywords
alkoxy
quinoxalins
preparation
formula
carbonyl
Prior art date
Application number
DK95116094T
Other languages
Danish (da)
English (en)
Inventor
Irvin Dr Winkler
Uta-Maria Billhardt-Troughton
Guenther Dr Riess
Joerg-Peter Dr Kleim
Manfred Dr Roesner
Reinhard Dr Kirsch
Christoph Dr Meichsner
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK0708093T3 publication Critical patent/DK0708093T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK95116094T 1994-10-19 1995-10-12 Quinoxaliner, fremgangsmåde til fremstilling deraf og deres anvendelse DK0708093T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4437406A DE4437406A1 (de) 1994-10-19 1994-10-19 Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
DK0708093T3 true DK0708093T3 (da) 2001-04-30

Family

ID=6531202

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95116094T DK0708093T3 (da) 1994-10-19 1995-10-12 Quinoxaliner, fremgangsmåde til fremstilling deraf og deres anvendelse

Country Status (27)

Country Link
US (1) US5723461A (fr)
EP (1) EP0708093B1 (fr)
JP (1) JPH08225544A (fr)
KR (1) KR960014108A (fr)
CN (1) CN1094930C (fr)
AT (1) ATE198747T1 (fr)
AU (1) AU708293B2 (fr)
BR (1) BR9504456A (fr)
CA (1) CA2160859A1 (fr)
CZ (1) CZ271295A3 (fr)
DE (2) DE4437406A1 (fr)
DK (1) DK0708093T3 (fr)
ES (1) ES2154311T3 (fr)
FI (1) FI954946A7 (fr)
GR (1) GR3035673T3 (fr)
HR (1) HRP950524B1 (fr)
HU (1) HUT73485A (fr)
IL (1) IL115641A0 (fr)
MY (1) MY132057A (fr)
NO (1) NO306615B1 (fr)
NZ (1) NZ280258A (fr)
PL (1) PL184860B1 (fr)
PT (1) PT708093E (fr)
SI (1) SI9500329A (fr)
SK (1) SK128495A3 (fr)
TW (1) TW328954B (fr)
ZA (1) ZA958783B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6369057B1 (en) * 1991-04-15 2002-04-09 Aventis Pharma Deutschland Gmbh Quinoxalines, processes for their preparation and their use
US6015800A (en) * 1997-09-03 2000-01-18 Warner-Lambert Company Substituted quinoxaline-2-ones as glutamate receptor antagonists
WO1999025327A2 (fr) * 1997-11-14 1999-05-27 Warner-Lambert Company Intervention de petites molecules dans la replication du vih-1
GB9901795D0 (en) * 1999-01-28 1999-03-17 Glaxo Group Ltd Chemical compounds
GB9911887D0 (en) * 1999-05-21 1999-07-21 Glaxo Group Ltd Methods and medicaments for post exposure prophylaxis of an hiv infection
WO2002087500A2 (fr) * 2001-04-27 2002-11-07 Newbiotics, Inc. Prototoxophores actives par une enzyme virale et leur utilisation dans le traitement des infections virales
WO2005018531A2 (fr) * 2003-08-26 2005-03-03 'chemical Diversity Research Institute', Ltd. Compositions pharmaceutiques, composes azo-heterocycliques et procedes de fabrication et d'utilisation correspondants
US7351709B2 (en) * 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
SI3459942T1 (sl) 2012-04-24 2021-05-31 Vertex Pharmaceuticals Incorporated Inhibitorji DNA-PK
HUE041544T2 (hu) 2013-03-12 2019-05-28 Vertex Pharma DNS-PK inhibitorok
PT3424920T (pt) 2013-10-17 2020-07-07 Vertex Pharma Co-cristais de (s)-n-metil-8-(1-((2'-metil-[4,5'-bipirimidin]-6-il)amino)propan-2-il)quinolina-4-carboxamida e derivados deuterados dos mesmos como inibidores de adn-pk
JP2019529475A (ja) 2016-09-27 2019-10-17 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated Dna損傷剤とdna−pk阻害剤との組合せ物を使用する、がんを処置するための方法
CN117580569A (zh) * 2021-07-02 2024-02-20 奥尔德拉医疗公司 杂环型醛捕获化合物和其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT509398E (pt) * 1991-04-15 2002-02-28 Aventis Pharma Gmbh Quinoxalinas processo para a sua preparacao e sua utilizacao
DE4342024A1 (de) * 1993-12-09 1995-06-14 Hoechst Ag Kombinationspräparate, enthaltend ein Chinoxalin und ein Nukleosid

Also Published As

Publication number Publication date
CZ271295A3 (en) 1996-08-14
NO306615B1 (no) 1999-11-29
PT708093E (pt) 2001-06-29
SI9500329A (en) 1996-04-30
CN1094930C (zh) 2002-11-27
MY132057A (en) 2007-09-28
GR3035673T3 (en) 2001-06-29
CA2160859A1 (fr) 1996-04-20
PL184860B1 (pl) 2003-01-31
AU708293B2 (en) 1999-07-29
HRP950524B1 (en) 2002-06-30
IL115641A0 (en) 1996-01-19
PL311016A1 (en) 1996-04-29
TW328954B (en) 1998-04-01
JPH08225544A (ja) 1996-09-03
FI954946L (fi) 1996-04-20
NO954139L (no) 1996-04-22
EP0708093A1 (fr) 1996-04-24
BR9504456A (pt) 1997-05-20
KR960014108A (ko) 1996-05-22
EP0708093B1 (fr) 2001-01-17
US5723461A (en) 1998-03-03
FI954946A0 (fi) 1995-10-17
HU9503005D0 (en) 1995-12-28
AU3431695A (en) 1996-05-02
CN1135483A (zh) 1996-11-13
HRP950524A2 (en) 1997-10-31
DE4437406A1 (de) 1996-04-25
HUT73485A (en) 1996-08-28
SK128495A3 (en) 1996-06-05
NO954139D0 (no) 1995-10-18
HK1011988A1 (en) 1999-07-23
ES2154311T3 (es) 2001-04-01
ATE198747T1 (de) 2001-02-15
FI954946A7 (fi) 1996-04-20
ZA958783B (en) 1996-05-09
DE59508969D1 (de) 2001-02-22
NZ280258A (en) 1997-09-22

Similar Documents

Publication Publication Date Title
DE68920773D1 (de) Chinoloncarbonsäure-Derivate.
ES8301962A1 (es) Un procedimiento para la produccion de un derivado de carboslivilo.
EP0493608A4 (en) Quinolonecarboxylic acid derivative
KR960014108A (ko) 퀴녹살린, 이의 제조방법 및 이의 용도
DE50005437D1 (en) Substituierte thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)one
ZA888186B (en) Quinolinecarboxylic acid derivatives
ES8504741A1 (es) Procedimiento para la preparacion de nuevos derivados de pirimidina o s-triacina.
ATE133938T1 (de) Indan-1,3-dion und indan-1,2,3-trionderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
ES8604717A1 (es) Procedimiento para la preparacion de nuevos derivados de 3-fenil-4-cianopirrol.
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
NZ324693A (en) 2-(O-[pyrimidin-4-yl]methylenoxy)phenyl acetic acid derivatives and fungicidal composition
NZ336091A (en) Aqueous disinfecting cleaning composition
DE69008466D1 (de) Verwendung des 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-Dimethyluracils zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Harnwegsverstopfungen.
DE3864193D1 (de) Substituierte 5-amino-pyrazole und diese enthaltende fungizide.
IL141009A0 (en) N-substituted azabicycloheptane derivatives, production and use thereof
DE69403896D1 (de) 4-amino-2-(hetero)aryl-butanamide verwenbar als 5-ht1a-antagonisten
AU606701B2 (en) Antipsychotic compositions containing dioxopiperidine derivatives
MX9705379A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis vasodilatadora.
DK0423870T3 (da) Dibenzodioxazecin- dibenzodioxaazacycloundecinderivater
ES459473A1 (es) Procedimiento para la preparacion de nuevas 9-alcohilamino- eritromicinas.
JO1825B1 (en) Therapeutic agents